中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01763 中国同辐

未开盘 05-13 16:08:33

11.620

-0.040

-0.34%

最高11.680	最低11.500	成交量10.88万
今开11.660	昨收11.660	日振幅1.54%
总市值37.17亿	流通市值9.29亿	总股本3.20亿
成交额126.28万	换手率0.14%	流通股本7,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":11.62,"timestamp":1747123713029,"preClose":11.66,"halted":0,"volume":108800,"delay":0,"floatShares":79968800,"shares":319874900,"eps":1.3771022153164882,"marketStatus":"未开盘","change":-0.04,"latestTime":"05-13 16:08:33","open":11.66,"high":11.68,"low":11.5,"amount":1262808,"amplitude":0.015437,"askPrice":11.62,"askSize":1800,"bidPrice":11.52,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":1.3771022153164882,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747186200000},"marketStatusCode":0,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":11.66,"dividendRate":0.035263,"openAndCloseTimeList":[[1747099800000,1747108800000],[1747112400000,1747123200000]],"volumeRatio":0.3651496844846473,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2533977153","title":"中国同辐05月08日主力净流入136.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533977153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533977153?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:15","pubTimestamp":1746692126,"startTime":"0","endTime":"0","summary":"05月08日, 中国同辐股价涨2.82%，报收11.68元，成交金额634.9万元，换手率0.68%，振幅3.52%，量比2.68。中国同辐今日主力资金净流入136.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.91%，主力资金累计净流入95.5万元；近20日主力资金累计净流入176.8万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173240a4767be7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508173240a4767be7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2533765922","title":"港股概念追踪|核药高壁垒造就寡头垄断格局   中金不断调升远大医药目标价（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2533765922","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533765922?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:26","pubTimestamp":1746689172,"startTime":"0","endTime":"0","summary":"在核药领域，港股最典型的就包括远大医药。据悉，5月6日，公司公告全球创新产品STC3141中国II期临床研究成功达到临床终点。该行认为若STC3141未来得以商业化，将和公司现有管线形成良好的协同。智通财经APP获悉，3月份中金研报给出远大医药目标价7.20港元；5月份又调升到8港元。核药赛道投融资交易火热，海外大药企争先入局。首次覆盖创新核药行业，给予“强于大市”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","HSTECH","YANG","01763","00512"],"gpt_icon":1},{"id":"2533308509","title":"中国同辐股份有限公司终止2025年度职业危害检测服务采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2533308509","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533308509?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:42","pubTimestamp":1746520922,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年05月06日，中国同辐股份有限公司发布了一则公告，宣布终止2025年度职业危害检测服务采购-中核安科锐项目。根据公告内容，此次终止的原因是参与有效供应商数量不足，经与需求部门沟通后决定停止本次寻源，并计划重新进行。该项目的招标编号为HJSB-FW-GKXJ-25-0638，发布时间为2025年04月17日，公告类型为中标结果。地点信息未知。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506164401975070ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506164401975070ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2531759428","title":"北京中强智尚知识产权代理有限公司等两家中标中国同辐股份有限公司项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2531759428","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531759428?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:35","pubTimestamp":1745937301,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年04月29日，中国同辐股份有限公司发布的知识产权代理服务-中核安科锐采购结果公告显示，北京中强智尚知识产权代理有限公司与北京壹川鸣知识产权代理事务所（特殊普通合伙）中标。该项目名称为知识产权代理服务-中核安科锐[2025-2027年中核安科锐知识产权代理服务]。此次公告未披露具体中标金额。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429223614974a4db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429223614974a4db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2530443881","title":"中国同辐财务共享中心财务业务外包服务项目中标结果公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2530443881","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530443881?lang=zh_cn&edition=full","pubTime":"2025-04-28 14:08","pubTimestamp":1745820482,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年04月28日，中国同辐财务共享中心财务业务外包服务项目的中标结果正式公布。该项目的公告由中核（上海）供应链管理有限公司发布，主管单位为中核集团经营管理部。截至目前，尚未披露具体的中标供应商及中标金额信息。公告来源于中国核工业集团有限公司电子采购平台。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814094494e56f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814094494e56f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2529926316","title":"中国同辐：2024年实现营业收入75.7亿元，同比增长14.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529926316","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529926316?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:03","pubTimestamp":1745456580,"startTime":"0","endTime":"0","summary":"来源：Gangtise投研中国同辐（01763.HK）2024年度业绩发布会：中国同辐，作为国内最大的诊断和治疗放射性药物供应商及医用钴-60源独家制造商，2024年实现营业收入75.7亿元，同比增长14.2%，净利润8.8亿元，同比增长13.3%，归母净利润4.1亿元，同比增长9.6%。公司业务涵盖核医学、放疗系统、工业辐射源等领域，提供全方位医疗解决方案。未来，随着技术创新、市场容量扩大、行业竞争加剧及医疗机构增加，中国同辐将继续聚焦核素创新、新靶点研发，拓展市场，应对竞争，助力国家健康战略，实现可持续发展。责任编辑：王若云","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409063094e03c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409063094e03c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763"],"gpt_icon":0},{"id":"2529363707","title":"中国同辐：原子高科2024年归属于挂牌公司股东的净利润2.96亿元 同比增加15.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529363707","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529363707?lang=zh_cn&edition=full","pubTime":"2025-04-22 08:29","pubTimestamp":1745281740,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　中国同辐（01763）发布附属原子高科2024年度报告，该集团实现营业收入17.47亿元（人民币，下同），同比增加7.18%；归属于挂牌公司股东的净利润2.96亿元，同比增加15.6%；基本每股收益1.83元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-22/doc-inetyyfa4339788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01763"],"gpt_icon":0},{"id":"2529723288","title":"中国同辐(01763)：原子高科2024年归属于挂牌公司股东的净利润2.96亿元 同比增加15.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529723288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529723288?lang=zh_cn&edition=full","pubTime":"2025-04-21 19:11","pubTimestamp":1745233874,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布附属原子高科2024年度报告，该集团实现营业收入17.47亿元(人民币，下同)，同比增加7.18%;归属于挂牌公司股东的净利润2.96亿元，同比增加15.6%;基本每股收益1.83元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"gpt_icon":0},{"id":"2527136233","title":"中国同辐04月14日获主力加仓36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527136233","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527136233?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:16","pubTimestamp":1744618609,"startTime":"0","endTime":"0","summary":"04月14日, 中国同辐股价涨2.50%，报收11.48元，成交金额676万元，换手率0.74%，振幅3.39%，量比1.53。中国同辐今日主力资金净流入36万元，连续3日净流入，上一交易日主力净流入43万元。该股近5个交易日上涨6.69%，主力资金累计净流入115万元；近20日主力资金累计净流入89万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171310a4584c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171310a4584c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2527582039","title":"中国同辐：氟化钠注射液通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2527582039","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527582039?lang=zh_cn&edition=full","pubTime":"2025-04-13 12:05","pubTimestamp":1744517100,"startTime":"0","endTime":"0","summary":"　　中国同辐附属原子高科发布公告，近日，该公司持有的氟化钠注射液顺利通过《药品生产质量管理规范》及附录要求的《药品生产质量管理规范》符合性检查，标志着该产品已具备全面市售资质。　　原子高科始终以“国际核科技发展引领者”为战略目标，依托强大的研发实力与 GMP 生产体系，持续推动核技术应用产业的高质量发展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-13/doc-inesyumz0624465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2518021996","title":"中国同辐03月10日主力净流出65万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518021996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518021996?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:15","pubTimestamp":1741594536,"startTime":"0","endTime":"0","summary":"03月10日，中国同辐股价收平报12.10元，成交金额602万元，换手率0.62%，振幅2.15%，量比1.88。中国同辐今日主力资金净流出65万元，上一交易日主力净流入49万元。该股近5个交易日上涨4.67%，主力资金累计净流入29万元；近20日主力资金累计净流入40万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165754a269b8e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165754a269b8e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2517362961","title":"中国同辐03月06日主力净流入44万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517362961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517362961?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:16","pubTimestamp":1741249015,"startTime":"0","endTime":"0","summary":"03月06日, 中国同辐股价涨1.91%，报收11.74元，成交金额548万元，换手率0.58%，振幅2.26%，量比2.83。中国同辐今日主力资金净流入44万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.01%，主力资金累计净流入44万元；近20日主力资金累计净流入9万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170022abeb1451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170022abeb1451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2517199469","title":"中国同辐签署百万居里设计装源量辐照站设备供应合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2517199469","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517199469?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:02","pubTimestamp":1741168975,"startTime":"0","endTime":"0","summary":"3月5日，中国同辐（01763）发布公告，近日公司与孟加拉业主成功签署百万居里设计装源量辐照站设备供应合同。这标志着公司在2024年成功中标孟加拉核农业研究院设计装源量百万居里伽马辐照站项目后，再次实现辐照站设备供应项目的落地。该辐照站建成后将主要服务于孟加拉医疗领域产品的辐照灭菌，显著提升当地医疗产品质量水平及生产加工能力，助力孟加拉医疗产业发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053337358010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01763","CRIS","BK1222","BK4139"],"gpt_icon":0},{"id":"2517991902","title":"中国同辐(01763)：在孟加拉再次落地辐照站设备供应项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991902","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517991902?lang=zh_cn&edition=full","pubTime":"2025-03-05 17:59","pubTimestamp":1741168750,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，近日，中国同辐与孟加拉业主成功签署百万居里设计装源量辐照站设备供应合同，标志着2024年成功中标孟加拉核农业研究院设计装源量百万居里伽马辐照站项目后，公司又一辐照站设备供应项目落地。该辐照站建成启用后主要服务于孟加拉医疗领域产品的辐照灭菌，将显著提升当地医疗产品质量水平及生产加工能力，助力孟加拉医疗产业发展，造福当地民生。中国同辐凭借定制化设计方案和全周期服务体系，成功攻克技术标准对接、设备适应性改造等关键难题，赢得孟加拉业主高度认可，实现了项目的持续获得，为中国同辐深耕孟加拉市场打造了典范，也为持续开拓国际市场树立了标杆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2509836299","title":"中国同辐盘中异动 早盘股价大涨5.29%报11.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509836299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509836299?lang=zh_cn&edition=full","pubTime":"2025-02-06 10:53","pubTimestamp":1738810437,"startTime":"0","endTime":"0","summary":"2025年02月06日早盘10时53分，中国同辐股票出现异动，股价大幅上涨5.29%。截至发稿，该股报11.140港元/股，成交量17.8万股，换手率0.22%，振幅6.99%。资金方面，该股资金流入152.732万港元，流出22.0596万港元。中国同辐股票所在的药品行业中，整体涨幅为0.27%。其相关个股中，联邦制药、海王英特龙、信达生物涨幅较大，振幅较大的相关个股有顺腾国际控股、联邦制药、信达生物，振幅分别为22.58%、9.86%、7.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206105357abc420fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206105357abc420fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2509029625","title":"中国同辐(01763)上涨5.29%，报11.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509029625","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509029625?lang=zh_cn&edition=full","pubTime":"2025-02-06 10:53","pubTimestamp":1738810437,"startTime":"0","endTime":"0","summary":"2月6日，中国同辐(01763)盘中上涨5.29%，截至10:53，报11.14元/股，成交193.13万元。中国同辐股份有限公司的主营业务为同位素制品和辐照加工，强化主业并致力于研发和市场拓展，以打造成为同位素及辐照加工行业的龙头企业。公司于2011年12月6日注册成立，注册资金23990.61万元，现有员工近2000人，是由中国核工业集团公司、中国原子能科学研究院和中国核动力研究设计院共同出资创建。截至2024年中报，中国同辐营业总收入28.1亿元、净利润1.54亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/06105347979511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2505449715","title":"中国同辐1月22日收盘下跌1.16%，成交44.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505449715","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505449715?lang=zh_cn&edition=full","pubTime":"2025-01-22 16:56","pubTimestamp":1737536219,"startTime":"0","endTime":"0","summary":"1月22日，截至港股收盘，恒生指数下跌1.63%，报19778.77点。中国同辐收报10.22港元/股，下跌1.16%，成交量4.36万股，成交额44.61万港元，振幅1.74%。最近一个月来，中国同辐累计跌幅1.15%，今年来累计跌幅4.79%，跑输恒生指数0.23%的涨幅。财务数据显示，截至2024年6月30日，中国同辐实现营业总收入28.1亿元，同比增长2.58%；归母净利润1.54亿元，同比增长23.19%；毛利率52.1%，资产负债率46.7%。2011年12月6日注册成立,注册资金23990.61万元,由十多个成员单位组成,现有员工近2000人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170131986f2665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170131986f2665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2502851385","title":"中国同辐(01763)：关秀妍担任授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2502851385","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502851385?lang=zh_cn&edition=full","pubTime":"2025-01-10 19:35","pubTimestamp":1736508939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，为畅通沟通渠道，香港联合交易所有限公司证券上市规则第3.05条所规定的授权代表之一将由张军旗先生变更为公司联席公司秘书之一关秀妍女士，即日生效。关秀妍女士将与公司另一位联席公司秘书王仓忍女士共同履行授权代表的有关职责。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1236266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":0.0375},{"period":"3month","weight":0.0211},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.07}],"compareEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":0.1049},{"period":"3month","weight":0.0572},{"period":"6month","weight":0.189},{"period":"1year","weight":0.2089},{"period":"ytd","weight":0.152}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.028471},{"month":2,"riseRate":0.571429,"avgChangeRate":0.05214},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.034117},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.013246},{"month":5,"riseRate":0.571429,"avgChangeRate":0.001409},{"month":6,"riseRate":0.5,"avgChangeRate":0.032122},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.044396},{"month":8,"riseRate":0.428571,"avgChangeRate":0.040863},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.027684},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.071533},{"month":11,"riseRate":0.714286,"avgChangeRate":0.05136},{"month":12,"riseRate":0.571429,"avgChangeRate":0.014563}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}